Citations

Showing 10 of 108083 citations.

Blockade of CCR1 induces a phenotypic shift in macrophages and triggers a favorable antilymphoma activity
Le, Kang , Sun, Jing , Ghaemmaghami, Javid, Ip, W. K. Eddie, Phillips, Tycel , Gupta, Mamta , Phillips, Tycel , Gupta, Mamta , Ghaemmaghami, Javid , Smith, Mitchell R.

Mayo Clinic

Blood Advances | January 11, 2023 | Volume: 7 | Issue: 15 | Pages: 3952-3967

10.1182/bloodadvances.2022008722 | PMID 36630565 Get It

Abstract Tumor-associated macrophages (TAMs) within the tumor microenvironment (TME) play an important role in tumor growth and progression. TAMs have been involved in producing immunosuppressive TME via various factors; however, the underlying mechanisms remain unclear in B-cell lymphoma, including mantle cell lymphoma (MCL). We identified that chemokine receptor-1 (CCR1) is highly expressed on monocytes (Mo) and macrophages (MΦ), and CCR1 pharmacological inhibition or CCR1 siRNA abolished lymphoma-mediated Mo/MΦ migration in a chemotaxis assay. The deficiency of host CCR1 (CCR1 KO) was associated with decreased infiltration of peritoneal-MΦ compared with WT-CCR1. Functional studies indicated that the genetic depletion of CCR1 or treatment inhibited protumor MΦ (M2-like) phenotype by decreasing CD206 and IL-10 expression. Moreover, CCR1 depletion reprogrammed MΦ toward an MHCII+/TNFα+ immunogenic phenotype. Mechanistically, protumor MΦ driven–IL-10 provides a positive feedback loop to tumor-CCL3 by regulating the CCL3 promoter via STAT1 signaling. Therapeutic in vivo targeting of CCR1 with CCR1 antagonist BX-471 significantly reduced FC-muMCL1 mouse tumors in the syngeneic MCL model by the depletion of M2-TAMs and increased infiltration of cytotoxic CD8+ T cells. Our study established that CCR1 exerts a pivotal role in macrophage programming, thus shaping protumor TME and lymphoma progression. CCR1 inhibition through CCR1 antagonists may be a promising therapeutic strategy to reprogram macrophages in lymphoma-TME and achieve better clinical outcomes in patients.
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
Budhraja, Karan K. , McDonald, Bradon R. , Stephens, Michelle D. , Contente‐Cuomo, Tania , Markus, Havell , Farooq, Maria , Favaro, Patricia Filippsen, Connor, Sydney , Byron, Sara A. , Egan, Jan B. , McDaniel, Timothy K., Sekulić, Aleksandar , Tran, Nhan L. , Prados, Michael D. , Pockaj, Barbara A. , LoRusso, Patricia , Bryce, Alan H. , Trent, Jeffrey M. , Favaro, Patricia F , Ernst, Brenda , Prados, Michael D , Borad, Mitesh J , Berens, Michael E , Pockaj, Barbara A , Bryce, Alan H , Trent, Jeffrey M , Murtaza, Muhammed , Tran, Nhan L , Ernst, Brenda , Borad, Mitesh J. , Berens, Michael E. , Murtaza, Muhammed

Mayo Clinic

Science Translational Medicine | January 11, 2023 | Volume: 15 | Issue: 678 | Pages: No page available

10.1126/scitranslmed.abm6863 | PMID 36630480 Get It

Genome-wide fragmentation patterns in cell-free DNA (cfDNA) in plasma are strongly influenced by cellular origin due to variation in chromatin accessibility across cell types. Such differences between healthy and cancer cells provide the opportunity for development of novel cancer diagnostics. Here, we investigated whether analysis of cfDNA fragment end positions and their surrounding DNA sequences reveals the presence of tumor-derived DNA in blood. We performed genome-wide analysis of cfDNA from 521 samples and analyzed sequencing data from an additional 2147 samples, including healthy individuals and patients with 11 different cancer types. We developed a metric based on genome-wide differences in fragment positioning, weighted by fragment length and GC content [information-weighted fraction of aberrant fragments (iwFAF)]. We observed that iwFAF strongly correlated with tumor fraction, was higher for DNA fragments carrying somatic mutations, and was higher within genomic regions affected by copy number amplifications. We also calculated sample-level means of nucleotide frequencies observed at genomic positions spanning fragment ends. Using a combination of iwFAF and nine nucleotide frequencies from three positions surrounding fragment ends, we developed a machine learning model to differentiate healthy individuals from patients with cancer. We observed an area under the receiver operative characteristic curve (AUC) of 0.91 for detection of cancer at any stage and an AUC of 0.87 for detection of stage I cancer. Our findings remained robust with as few as 1 million fragments analyzed per sample, demonstrating that analysis of fragment ends can become a cost-effective and accessible approach for cancer detection and monitoring.
Perioperative management of emergency and elective surgeries during the pandemic
Boike, Sydney , Mir, Mikael , Olson, Holly , Cole, Delaney , Rauf, Ibtisam , Surani, Salim , Khan, Syed Anjum , Surani, Salim , Boike, Sydney , Khan, Syed Anjum , Olson, Holly

Mayo Clinic

Hospital Practice | January 11, 2023 | Volume: 51 | Issue: 1 | Pages: 12-17

10.1080/21548331.2023.2166746 | PMID 36629125 Get It

Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis
Fleming, Andrew M. , Deschner, Benjamin W. , Williard, Forrest W., Xiu, Joanne , Somer, Bradley G. , Yakoub, Danny , Tsao, Miriam , Glazer, Evan S. , Dickson, Paxton V. , Shibata, David , Hwang, Jimmy J., Shields, Anthony F. , Lenz, Heinz‐Josef , Deneve, Jeremiah L. , Glazer, Evan S , Dickson, Paxton V , Deneve, Jeremiah L , Reiter, Audra , Drake, Justin A. , Vanderwalde, Ari M. , Philip, Philip A. , Marshall, John L , Korn, Wolfgang Michael

Mayo Clinic

Journal of Surgical Oncology | January 11, 2023 | Volume: 127 | Issue: 5 | Pages: 815-822

10.1002/jso.27198 | PMID 36629137 Get It

AbstractBackground and ObjectivesPublished data comparing peritoneal metastases from appendiceal cancers (pAC) and colorectal cancers (pCRC) remain sparse. We compared pAC and pCRC using comprehensive tumor profiling (CTP).MethodsCTP was performed, including next‐generation sequencing and analysis of copy number variation (CNV), microsatellite instability (MSI) and tumor mutational burden (TMB).ResultsOne hundred thirty‐six pAC and 348 pCRC samples underwent CTP. The cohorts' age and gender were similar. pCRC demonstrated increased pathogenic variants (PATHs) in APC (48% vs. 3%, p < 0.01), ARID1A (12% vs. 2%, p < 0.01), BRAF (12% vs. 2%, p < 0.01), FBXW7 (7% vs. 2%, p < 0.01), KRAS (52% vs. 41%, p < 0.05), PIK3CA (15% vs. 2%, p < 0.01), and TP53 (53% vs. 23%, p < 0.01), and decreased PATHs in GNAS (8% vs. 31%, p < 0.01). There was no difference in CNV, fusion rate, or MSI. Median TMB was higher in pCRC (5.8 vs. 5.0 mutations per megabase, p = 0.0007). Rates of TMB‐high tumors were similar (pAC 2.1% vs. pCRC 9.0%, p = 0.1957). pCRC had significantly more TMB‐high tumors at lower thresholds.ConclusionsDespite a reduced overall TMB, pAC demonstrated mutations distinct from those seen in pCRC. These may serve as discrete biomarkers for future study.
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022
Baehring, Joachim M. , Butowski, Nicholas , Cannon, Donald M. , Chao, Samuel T. , Chheda, Milan G. , Fabiano, Andrew J. , Gigilio, Pierre, Hattangadi‐Gluth, Jona A. , Holdhoff, Matthias , Junck, Larry , Merrell, Ryan , Mrugała, Maciej M. , Nagpal, Seema , Nedzi, Lucien , Nevel, Kathryn , Patel, Toral , Peters, Katherine B. , Rockhill, Jason K., Rusthoven, Chad G. , Shonka, Nicole , Swinnen, Lode J., Weiss, Stephanie E. , Wen, Patrick Y. , Willmarth, Nicole E. , Bergman, Mary Anne, Darlow, Susan, Peters, Katherine B , Nagpal, Seema , Patel, Toral R , Horbinski, Craig , Nabors, Burt , Portnow, Jana , Bhatia, Ankush , Bloch, Orin G. , Brem, Steven , Forsyth, Peter A , Kaley, Thomas , Nghiemphu, Phioanh L. , Parney, Ian F. , Puduvalli, Vinay K. , Wen, Patrick Yung

Mayo Clinic

Journal of the National Comprehensive Cancer Network | January 11, 2023 | Volume: 21 | Issue: 1 | Pages: 12-20

10.6004/jnccn.2023.0002 | PMID 36634606 Get It

The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (WHO grade 1, WHO grade 2–3 oligodendroglioma [1p19q codeleted, IDH- mutant], WHO grade 2–4 IDH- mutant astrocytoma, WHO grade 4 glioblastoma), intracranial and spinal ependymomas, medulloblastoma, limited and extensive brain metastases, leptomeningeal metastases, non–AIDS-related primary CNS lymphomas, metastatic spine tumors, meningiomas, and primary spinal cord tumors. The information contained in the algorithms and principles of management sections in the NCCN Guidelines for CNS Cancers are designed to help clinicians navigate through the complex management of patients with CNS tumors. Several important principles guide surgical management and treatment with radiotherapy and systemic therapy for adults with brain tumors. The NCCN CNS Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding molecular profiling of gliomas.
Life before Death in India: A Narrative Review
Misra, Sudha , Sanghavi, Devang , Mir, Wasey Ali Yadullahi , Misra, Sudha

Mayo Clinic

Indian Journal of Palliative Care | January 11, 2023 | Volume: 29 | Issue: No issue available | Pages: 207-211

10.25259/ijpc_44_2022 | PMID 37325266 Get It

Palliative care is an ever-increasing need in India, with its large population and rising burden of chronic illness. India ranks 67thout of 80 countries in the quality of death index, which measures the availability and quality of palliative care. Community-led projects in Kerala have proven successful in improving palliative care access with modest resources and volunteer involvement. In India, the number of hospice facilities is increasing; however, <1% of the Indian population has access to palliative care. Financial and human resources limitations in the health-care system, poverty and high health-care expenditure, the lack of awareness among the public about end-of-life care, hesitance to seek care due to social stigma, strict laws regarding opiates that hinder adequate pain relief and the apparent conflict between traditional social values and western values regarding death are the major obstacles to improving palliative care. Significant efforts focused on public awareness of end-of-life care and locally-tailored programmes with family and community involvement are necessary to address this issue and integrate palliative care into the primary care system. Furthermore, we discuss the effects of the COVID-19 pandemic that has been managed effectively by palliative care involvement.
Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma
Desai, Sanjal H. , David, Kevin A. , Bachanová, Veronika , Goyal, Gaurav , Dorritie, Kathleen , Kenkre, Vaishalee P. , Arai, Sally , Chang, Cheryl , Fusco, Brendon , Hatic, Haris, Saba, Raya , Harris, Elyse I., Shah, Harsh , Murphy, Jacob, Ansell, Stephen M. , Jagadish, Deepa, Diefenbach, Catherine , Iyenger, S., Rappazzo, K. C., Choi, Yun Young , Nowakowski, Grzegorz S. , Advani, Ranjana H. , Micallef, Ivana N. , David, Kevin , Bachanova, Veronika , Goyal, Guarav , Sumransub, Nuttavut , Shah, Harsh , Ansell, Stephen M , Advani, Ranjana H , Desai, Sanjal , Diefenbach, Catherine S , Spinner, Michael A. , Kahl, Brad S. , Azzi, Jacques Mario , Ibrahim, Uroosa , Murphy, Jacob, Orellana‐Noia, Victor M. , Mishra, Rahul

Mayo Clinic

American Journal of Hematology | January 11, 2023 | Volume: 98 | Issue: 3 | Pages: 464-471

10.1002/ajh.26827 | PMID 36629030 Get It

AbstractClinical trials of novel salvage therapies have encouraging outcomes for relapsed/refractory transplant‐eligible classic Hodgkin lymphoma (R/R cHL) but comparison with conventional chemotherapy is lacking. Herein, we report the final analysis of a multicenter retrospective cohort of R/R cHL assessing outcomes by type of salvage therapy before autologous stem cell transplant (ASCT). R/R cHL patients who underwent ASCT at 14 institutions across the United States were included. Outcomes were compared among patients receiving conventional chemotherapy, brentuximab vedotin (BV) + chemotherapy, BV alone, and a checkpoint inhibitor (CPI)‐based regimens before ASCT. Study endpoints included event‐free survival (EFS), progression‐free survival (PFS), and overall survival (OS). All endpoints are defined from relapse. Of 936 patients, 728 received conventional chemotherapy, 73 received BV + chemotherapy, 70 received BV alone, and 65 received CPI‐based regimens prior to ASCT. When adjusted for time to relapse, pre‐ASCT response and use of BV maintenance, patients receiving CPI‐based regimens had superior 2‐year EFS compared to conventional chemotherapy, BV + chemotherapy, and BV alone (79.7, 49.6, 62.3, and 36.9%, respectively, p < .0001). Among 649 patients transplanted after 1 line of salvage therapy, CPI‐based regimens were associated with superior 2‐year PFS compared to conventional chemotherapy (98% vs. 68.8%, hazard ratio: 0.1, 95% confidence interval: 0.03–0.5, p < .0001). OS did not differ by pre‐ASCT salvage regimen. In this large multicenter retrospective study, CPI‐based regimens improved EFS and PFS compared to other salvage regimens independent of pre‐ASCT response. These data support earlier sequencing of CPI‐based regimens in R/R cHL in the pre‐ASCT setting.
Session details: Electronic health systems interoperability and integration
Cui, Tao, Tao, Cui

Mayo Clinic

Proceedings of the 2nd international workshop on Managing interoperability and compleXity in health systems | January 11, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1145/3251598 Get It

Session details: Ontology-based application on clinical data
Jiang, Guoqian

Mayo Clinic

Proceedings of the 2nd international workshop on Managing interoperability and compleXity in health systems | January 11, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1145/3251597 Get It

Modulation of Cerebral Function by Muscle Afferent Activity, with Reference to Intravenous Succinylcholine
Lanier, William L.

Mayo Clinic

Anesthesiology | January 11, 2023 | Volume: 138 | Issue: 2 | Pages: 209-215

10.1097/aln.0000000000004437 | PMID 36629464 Get It

Cerebral Function and Muscle Afferent Activity Following Intravenous Succinylcholine in Dogs Anesthetized with Halothane: The Effects of Pretreatment with a Defasciculating Dose of Pancuronium. By WL Lanier, PA Iaizzo, and JH Milde. Anesthesiology 1989; 71:87–95. Reprinted with permission. By the mid-1980s, it was widely assumed that if the depolarizing muscle relaxant, succinylcholine, given IV, produced increases in intracranial pressure, it did so because fasciculations produced increases in intrathoracic and central venous pressures that were transferred to the brain; however, there was no direct evidence that this was true. In contrast, we explored the possibility that the succinylcholine effect on the brain was explained by the afferentation theory of cerebral arousal, which predicts that agents or maneuvers that stimulate muscle stretch receptors will tend to stimulate the brain. Our research in tracheally intubated, lightly anesthetized dogs discovered that IV succinylcholine (which does not cross the blood-brain barrier) produced a doubling of cerebral blood flow that lasted for 30 min and corresponded to activation of the electroencephalogram and increases in intracranial pressure. Later, in our Classic Paper, we were able to assess simultaneously cerebral physiology and afferent nerve traffic emanating from muscle stretch receptors (primarily muscle spindles). We affirmed that the cerebral arousal response to succinylcholine was indeed driven by muscle afferent traffic and was independent of fasciculations or increases in intrathoracic or central venous pressures. Later research in complementary models demonstrated that endogenous movement (e.g., coughing, hiccups) produced a cerebral response very similar to IV succinylcholine, apparently as a result of the same muscle afferent mechanisms, independent of intrathoracic and central venous pressures. Thus, the importance of afferentation theory as a driver of the cerebral state of arousal and cerebral physiology during anesthesia was affirmed.